New report examines new drugs in the pipeline that may significantly impact future drug spending in Canada
Imported from official source
Oncology continued to dominate the therapeutic mix of the drug pipeline in 2022.
This version
- Version
- 1 of 1
- Recorded
- October 03, 2026 20:43
- Change
- Initial
- Content hash
55b9fb366d01e33c98822a1ad8573f58- All versions
- Revision history